Our studies uncover the role of HDAC3 in facilitating NF-κB activation and inflammatory responses by preventing cathepsin-mediated RIP1 degradation as well as the requirement of its expression in macrophages for host defense against bacterial infection, which indicates the importance of future work in considering the risk factors of infections in the clinical applications of HDAC inhibitors. This evidence concerns the gene NFKB1 and infection.